Targeted MRI/ultrasound beats standard biopsy to detect high-risk prostate cancer
Tuesday, January 27, 2015 - 15:50
in Physics & Chemistry
Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study.